Davis Investment Partners’s Eli Lilly LLY Stock Holding History

Davis Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Buy	1,206 +13	+1%	+$13.2K	0.39%	45
2025 Q4	$1.29M	Buy	1,193 +102	+9%	+$97.5K	0.45%	45
2025 Q3	$901K	Hold	1,091	–	–	0.31%	50
2025 Q2	$847K	Sell	1,091 -32	-3%	-$24.9K	0.3%	53
2025 Q1	$847K	Buy	1,123 +62	+6%	+$51.6K	0.37%	49
2024 Q4	$849K	Buy	1,061 +204	+24%	+$169K	0.36%	52
2024 Q3	$763K	Sell	857 -47	-5%	-$42.3K	0.32%	60
2024 Q2	$857K	Buy	904 +70	+8%	+$56K	0.35%	56
2024 Q1	$636K	Buy	+834	New	+$594K	0.28%	66

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Davis Investment Partners's LLY Position: Q1 2026 in Review

Davis Investment Partners increased its Eli Lilly (LLY) stake by 1.1% in Q1 2026, buying an estimated $13.2K and bringing the position to 1,206 shares worth $1.11M. The position accounts for 0.39% of the portfolio, ranked #45.

Davis Investment Partners first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.29M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Davis Investment Partners held 1,206 shares of Eli Lilly worth $1.11M as of Q1 2026.
Davis Investment Partners bought 13 Eli Lilly shares in Q1 2026, an estimated $13.2K.
Eli Lilly made up 0.39% of Davis Investment Partners's portfolio in Q1 2026, its #45 holding.
Davis Investment Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
Davis Investment Partners's Eli Lilly position peaked at $1.29M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Davis Investment Partners's 13F filing for Q1 2026, filed 20 Apr 2026.